The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Therapeutic effects of metformin on insulin resistance and hyperandrogenism in polycystic ovary syndrome
Abstract
Evidence suggests that insulin resistance and hyperinsulinaemia are associated with ovarian hyperandrogenism and menstrual irregularities in polycystic ovary syndrome (PCOS). Sixteen obese women with PCOS on a weight-maintaining diet were studied before and after 6 months of therapy with the insulin-sensitizing antidiabetic agent metformin at a dose of 1700 mg per day. Compared with baseline values, glucose utilization was markedly enhanced at 6 months using the two-step euglycaemic-hyperinsulinaemic clamp to measure changes in insulin sensitivity (2.56 +/- 0.32 vs 4.68 +/- 0.49 mg/kg per min, P = 0.0001, when 40 mU insulin/m2 per min was infused, and 6.48 +/- 0.58 vs 9.84 +/- 0.72 mg/kg per min, P = 0.0002, when 400 mU insulin insulin/m2 per min was infused). The improvement in insulin action was accompanied by significant increases in the levels of sex hormone-binding globulin (24.5 +/- 7.2 vs 39.8 +/- 16.2 nmol/l, P = 0.003) and decreases in free testosterone (12.8 +/- 5.8 vs 9.0 +/- 3.0 pmol/l, P = 0.03) and androstenedione (12.9 +/- 5.6 vs 7.3 +/- 1.7 nmol/l, P = 0.003). No significant changes were recorded in body weight. Seven subjects resumed normal menstruation and two cases of spontaneous pregnancy occurred during treatment. Metformin was well tolerated except for one case of flatulence. These results confirm that metformin treatment can lead to improvements in insulin resistance and ovarian hyperandrogenism.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Glucose clamp technique: a method for quantifying insulin secretion and resistance.
DeFronzo, R. A., Tobin, J. D., & Andres, R. (1979) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1979.237.3.e214 · Cited by 7,425
Profound Peripheral Insulin Resistance, Independent of Obesity, in Polycystic Ovary Syndrome
Dunaif, A., Segal, K. R., Futterweit, W., & Dobrjansky, A. (1989) · Diabetes · doi:10.2337/diab.38.9.1165 · Cited by 1,967
POLYCYSTIC OVARIES—A COMMON FINDING IN NORMAL WOMEN
Polson, D. W., Wadsworth, J., Adams, J., & Franks, S. (1988) · The Lancet · doi:10.1016/s0140-6736(88)91612-1 · Cited by 906
Velazquez, E. M., Mendoza, S., Hamer, T., Sosa, F., & Glueck, C. J. (1994) · Metabolism · doi:10.1016/0026-0495(94)90209-7 · Cited by 865
Nestler, J. E., & Jakubowicz, D. J. (1996) · New England Journal of Medicine · doi:10.1056/nejm199608293350902 · Cited by 743
Insulin resistance in nonobese patients with polycystic ovarian disease
CHANG, R. J., NAKAMURA, R. M., JUDD, H. L., & KAPLAN, S. A. (1983) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-57-2-356 · Cited by 704
REVIEW ARTICLE: THE POLYCYSTIC OVARY SYNDROME
YEN, S. S. C. (1980) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1980.tb02132.x · Cited by 698
BARBIERI, R. L., MAKRIS, A., RANDALL, R. W., DANIELS, G., KISTNER, R. W., & RYAN, K. J. (1986) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-62-5-904 · Cited by 630
Bailey, C. J. (1992) · Diabetes Care · doi:10.2337/diacare.15.6.755 · Cited by 593
DUNAIF, A., GRAF, M., MANDELI, J., LAUMAS, V., & DOBRJANSKY, A. (1987) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-65-3-499 · Cited by 586
Evidence for Distinctive and Intrinsic Defects in Insulin Action in Polycystic Ovary Syndrome
Dunaif, A., Segal, K. R., Shelley, D. R., Green, G., Dobrjansky, A., & Licholai, T. (1992) · Diabetes · doi:10.2337/diab.41.10.1257 · Cited by 546
Dunaif, A., Scott, D., Finegood, D., Quintana, B., & Whitcomb, R. (1996) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.81.9.8784087 · Cited by 524
Turner, R., Cull, C., Holman, R., & United Kingdom Prospective Diabetes Study Group (1996) · Annals of Internal Medicine · doi:10.7326/0003-4819-124-1_part_2-199601011-00011 · Cited by 465
Dunn, C. J., & Peters, D. H. (1995) · Drugs · doi:10.2165/00003495-199549050-00007 · Cited by 391
NESTLER, J. E., BARLASCINI, C. O., MATT, D. W., STEINGOLD, K. A., PLYMATE, S. R., CLORE, J. N., & BLACKARD, W. G. (1989) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-68-6-1027 · Cited by 338 · cited 1×
“Furthermore, it has been shown that acute increments in insulin levels in women with PCOS induce rises in androgen levels (11, 12) whereas a reduction in serum insulin through the use of diazoxide to supress insulin secretion is reported to significantly reduce serum testosterone ( 13 ).”
BackgroundEhrmann, D. A., Cavaghan, M. K., Imperial, J., Sturis, J., Rosenfield, R. L., & Polonsky, K. S. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.82.2.3722 · Cited by 336
Crave, J. C. (1995) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.80.7.2057 · Cited by 302
Barbieri, R. L., & Ryan, K. J. (1983) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(83)90091-1 · Cited by 294
Moghetti, P. (1996) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.81.3.952 · Cited by 245
Defects in beta-cell function in functional ovarian hyperandrogenism
O'Meara, N. M. (1993) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.76.5.1241 · Cited by 245
Can metformin reduce insulin resistance in polycystic ovary syndrome?
Açbay, Ö., & Gündoğdu, S. (1996) · Fertility and Sterility · doi:10.1016/s0015-0282(16)58266-1 · Cited by 174
Insulin as an Effector of Human Ovarian and Adrenal Steroid Metabolism
Nestler, J. E., & Strauss, J. F. (1991) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(18)30245-7 · Cited by 141
Insulin sensitivity and antiandrogenic therapy in women with polycystic ovary syndrome
Diamanti‐Kandarakis, E., Mitrakou, A., Hennes, M. M. I., Platanisiotis, D., Kaklas, N., Spina, J., Georgiadou, E., Hoffmann, R. G., Kissebah, A. H., & Raptis, S. A. (1995) · Metabolism · doi:10.1016/0026-0495(95)90062-4 · Cited by 128
Self-citationMetformin improves peripheral but not hepatic insulin action in obese patients with type II diabetes
Nielsen, O. H., Schmitz, O., Andersen, P. H., Beck‐Nielsen, H., & Pedersen, O. B. (1989) · European Journal of Endocrinology · doi:10.1530/acta.0.1200257 · Cited by 118
Widén, E., Eriksson, J. G., & Groop, L. (1992) · Diabetes · doi:10.2337/diab.41.3.354 · Cited by 110
Regulation of sex hormone-binding globulin production by growth factors
Plymate, S. R., Hoop, R. C., Jones, R. E., & Matej, L. A. (1990) · Metabolism · doi:10.1016/0026-0495(90)90309-z · Cited by 102
ACTH Stimulation Tests and Plasma Dehydroepiandrosterone Sulfate Levels in Women with Hirsutism
Siegel, S. F., Finegold, D. N., Lanes, R., & Lee, P. A. (1990) · New England Journal of Medicine · doi:10.1056/nejm199009273231301 · Cited by 99
Peiris, A. N., Aiman, E. J., Drucker, W. D., & Kissebah, A. H. (1989) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-68-4-715 · Cited by 84
The relationship of insulin to sex hormone-binding globulin: role of adiposity
Peiris, A. N., Sothmann, M. S., Aiman, E. J., & Kissebah, A. H. (1989) · Fertility and Sterility · doi:10.1016/s0015-0282(16)60791-4 · Cited by 79
New perspectives in polycystic ovary syndrome
Diamanti‐Kandarakis, E., & Dunaif, A. E. (1996) · Trends in Endocrinology and Metabolism · doi:10.1016/s1043-2760(96)00125-7 · Cited by 70
Self-citationDorella, M., Giusto, M., Tos, V. D., Campagnolo, M., Palatini, P., Rossi, G., Ceolotto, G., Felice, M., Semplicini, A., & Prato, S. D. (1996) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.81.4.8636369 · Cited by 46
Ovarian hyperandrogenism with normal and abnormal histologic findings of the ovaries
Kim, M. H., Rosenfield, R. L., Hosseinian, A. H., & Schneir, H. (1979) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(16)33087-3 · Cited by 45
Scheen, A. J., Letiexhe, M. R., & Lefèbvre, P. J. (1995) · Diabetic Medicine · doi:10.1111/j.1464-5491.1995.tb00410.x · Cited by 27
Lasco, A., Cucinotta, D., Gigante, A., Denuzzo, G., Pedulla, M., Trifiletti, A., & Frisina, N. (1995) · European Journal of Endocrinology · doi:10.1530/eje.0.1330718 · Cited by 20
Cited by
Diamanti-Kandarakis, E., & Dunaif, A. (2012) · Endocrine Reviews · doi:10.1210/er.2011-1034 · Cited by 1,947
Self-citationThe Insulin-Related Ovarian Regulatory System in Health and Disease
Poretsky, L., Cataldo, N. A., Rosenwaks, Z., & Giudice, L. C. (1999) · Endocrine Reviews · doi:10.1210/edrv.20.4.0374 · Cited by 818
Franks, S. (1997) · Archives of Disease in Childhood · doi:10.1136/adc.77.1.89 · Cited by 806
Obesity and reproductive disorders in women
Pasquali, R. (2003) · Human Reproduction Update · doi:10.1093/humupd/dmg024 · Cited by 539
Ovulatory and Metabolic Effects of d-Chiro-Inositol in the Polycystic Ovary Syndrome
Nestler, J. E., Jakubowicz, D. J., Reamer, P., Gunn, R. D., & Allan, G. (1999) · New England Journal of Medicine · doi:10.1056/nejm199904293401703 · Cited by 518
Metadata
- Authors
- Diamanti-Kandarakis, E., Kouli, C., Tsianateli, T., & Bergiele, A.
- Venue
- European Journal of Endocrinology
- Publisher
- Oxford University Press (OUP)
- Published
- 1998-03-01
- Volume
- 138
- Issue
- 3
- Pages
- 269-274
- ISSN
- 0804-4643 (ISSN-L)
- 1479-683X
- OpenAlex
- W2153485075
- Cited by
- 323
- References
- 34
- FWCI
- 18.11
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.